Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin

The occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy. Thus, the need for alternative treatments is essential. Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C. difficile through several pub...

Full description

Saved in:
Bibliographic Details
Main Authors: Dominador Lao, Tom Chiang, Eric Gomez
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2012/702910
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413483386372096
author Dominador Lao
Tom Chiang
Eric Gomez
author_facet Dominador Lao
Tom Chiang
Eric Gomez
author_sort Dominador Lao
collection DOAJ
description The occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy. Thus, the need for alternative treatments is essential. Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C. difficile through several published case reports and in in vitro studies. We present a case of C. difficile colitis that failed to respond to metronidazole and oral vancomycin therapy, but improved on a combination of rifaximin, tigecycline, and vancomycin.
format Article
id doaj-art-6f2e786a1dd8401d9cd5dc31d1e2db59
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-6f2e786a1dd8401d9cd5dc31d1e2db592025-08-20T03:34:05ZengWileyCase Reports in Medicine1687-96271687-96352012-01-01201210.1155/2012/702910702910Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and VancomycinDominador Lao0Tom Chiang1Eric Gomez2St. Matthew’s School of Medicine, USAVeterans Affairs New Jersey Healthcare System (VA NJHCS), East Orange, NJ 07018, USADepartment of Infectious Disease, Appalachian Regional Hospital, Beckley, WV 25801, USAThe occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy. Thus, the need for alternative treatments is essential. Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C. difficile through several published case reports and in in vitro studies. We present a case of C. difficile colitis that failed to respond to metronidazole and oral vancomycin therapy, but improved on a combination of rifaximin, tigecycline, and vancomycin.http://dx.doi.org/10.1155/2012/702910
spellingShingle Dominador Lao
Tom Chiang
Eric Gomez
Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
Case Reports in Medicine
title Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
title_full Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
title_fullStr Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
title_full_unstemmed Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
title_short Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
title_sort refractory clostridium difficile infection successfully treated with tigecycline rifaximin and vancomycin
url http://dx.doi.org/10.1155/2012/702910
work_keys_str_mv AT dominadorlao refractoryclostridiumdifficileinfectionsuccessfullytreatedwithtigecyclinerifaximinandvancomycin
AT tomchiang refractoryclostridiumdifficileinfectionsuccessfullytreatedwithtigecyclinerifaximinandvancomycin
AT ericgomez refractoryclostridiumdifficileinfectionsuccessfullytreatedwithtigecyclinerifaximinandvancomycin